Association of altered cortical gyrification and psychopathological symptoms in patients with first-episode drug-naïve schizophrenia

Asian J Psychiatr. 2021 Oct:64:102749. doi: 10.1016/j.ajp.2021.102749. Epub 2021 Jul 9.

Abstract

Altered brain gyrification in diverse cortical regions has been reported in patients with schizophrenia, which possibly reflects deviations in early neurodevelopment. The main purpose of this study was to examine the relationship between clinical symptoms and abnormal cortical gyrification in drug-naïve patients with schizophrenia in a Chinese Han population. We calculated the whole-brain cortical gyrification of 41 patients with first-episode drug-naïve schizophrenia and 30 age- and sex-matched healthy controls. The Positive and Negative Syndrome Scale (PANSS) was used to evaluate the psychopathology of patients with schizophrenia. Our results showed that compared to healthy controls, patients had higher cortical gyrification in the left lateral occipital cortex, but lower cortical gyrification in the left transverse temporal cortex. Moreover, the cortical gyrification in the left entorhinal cortex and left fusiform were both positively correlated with the general psychopathology of PANSS. Our findings indicate that abnormal cortical gyrification has occurred in the early stage of schizophrenia, suggesting that abnormal cortical gyrification may play an important role in the pathogenesis and symptomatology of schizophrenia.

Keywords: Clinical symptoms; Cortical gyrification; First-episode drug-naïve schizophrenia; Positive and negative syndrome scale.

MeSH terms

  • Brain
  • Humans
  • Magnetic Resonance Imaging
  • Pharmaceutical Preparations*
  • Schizophrenia* / diagnostic imaging
  • Temporal Lobe

Substances

  • Pharmaceutical Preparations